| answer text |
<p>The National Institute for Health Research (NIHR) Evaluation, Trials and Studies
Coordinating Centre manages the Efficacy and Mechanism Evaluation programme. With
funding from the Medical Research Council, this programme is currently supporting
a £3.3 million trial of repeated application of gene therapy in patients with cystic
fibrosis. The report of this trial is expected to be published in August 2015.</p><p>
</p><p><strong> </strong></p><p> </p><p>A range of commercial and researcher-led cystic
fibrosis treatment trials and studies are hosted by NIHR research infrastructure including
the NIHR Clinical Research Network, NIHR biomedical research centres and units, and
NIHR clinical research facilities for experimental medicine.</p><p> </p><p><strong>
</strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p>
</p><p><strong> </strong></p><p> </p>
|
 |
